Startseite Understanding the cellular mode of action of vernakalant using a computational model: answers and new questions
Artikel Open Access

Understanding the cellular mode of action of vernakalant using a computational model: answers and new questions

  • Axel Loewe EMAIL logo , Yan Xu , Eberhard P. Scholz , Olaf Dössel und Gunnar Seemann
Veröffentlicht/Copyright: 12. September 2015
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Vernakalant is a new antiarrhythmic agent for the treatment of atrial fibrillation. While it has proven to be effective in a large share of patients in clinical studies, its underlying mode of action is not fully understood. In this work, we aim to link experimental data from the subcellular, tissue, and system level using an in-silico approach. A Hill’s equation-based drug model was extended to cover the frequency dependence of sodium channel block. Two model variants were investigated: M1 based on subcellular data and M2 based on tissue level data. 6 action potential (AP) markers were evaluated regarding their dose, frequency and substrate dependence. M1 comprising potassium, sodium, and calcium channel block reproduced the reported prolongation of the refractory period. M2 not including the effects on potassium channels reproduced reported AP morphology changes on the other hand. The experimentally observed increase of ERP accompanied by a shortening of APD90 was not reproduced. Thus, explanations for the drug-induced changes are provided while none of the models can explain the effects in their entirety. These results foster the understanding of vernakalant’s cellular mode of action and point out relevant gaps in our current knowledge to be addressed in future in-silico and experimental research on this aspiring antiarrhythmic agent.

1 Introduction

Atrial fibrillation (AF) is the most common sustained arrhythmia in humans affecting almost 2% of the population in the developed world [1]. As the two major strategies ablation therapy and drug therapy fail to succeed in about one third of all patients, AF is still a major challenge motivating the search for new drugs. Current antiarrhythmic agents suffer from limited efficacy or severe side-effects such as provoking life-threatening torsades de pointes arrhythmia in the ventricles. Vernakalant is a new multichannel blocker for pharmacological cardioversion of AF and proved to be superior to both placebo and the existing intravenous agent amiodarone in several clinical studies [1]. Despite its clinical efficacy, the underlying mode of action on atrial myocytes is not understood. One experimental study investigated the effect on isolated ion channels [2]. Wettwer et al. assessed the effect on tissue preparations [3] and Dorian et al. [4] studied the effect on atrial and ventricular refractory period in humans. However, these results on different integration levels could not be linked until now. In this work, we try to elucidate the complex non-linear effects of vernakalant on the cellular level by linking the experimental data from the single channel level to tissue level data.

2 Methods

2.1 Electrophysiological model

Cellular electrophysiology was modeled using the Courtemanche-Ramirez-Nattel model of human atrial myocytes [5] in the Control case. To represent chronic AF (cAF) induced remodeling, several conductivities were altered as described before [6]. In brief, Ito was reduced by 65%, IK1 was increased by 100%, IKs was increased by 100%, IKur was reduced by 50%, ICaL was reduced by 55%, INa, Ca was increased by 60%, and the SR leak current was increased by 50%. Furthermore, the cell capacitance was increased by 20%.

An implementation of the monodomain model [7] was utilized to simulate excitation propagation in a one-dimensional tissue strand of size 20 × 0.1 × 0.1mm3. The domain was discretized by cubic voxels with a side length of 0.1mm. The monodomain conductivity was set to 76 mS/m yielding a conduction velocity of 750 mm/s in theControl model without any drug-induced changes at a frequency of 1 Hz. Each voxel of the system was initialized in a single-cell environment for 50 beats followed by 5 beats in the tissue strand to adapt to the stimulation frequency. Stimuli were applied in voxels # 0..2, action potentials (APs) were evaluated in voxel # 150 as described before [8].

Table 1

Frequency-dependent IC50 /nH estimations for INa based on dVm/dtmax reduction data [3].

M1M2
IC50nHIC50nH
(μM)(μM)
0.5 Hz36.152.6735.792.67
Control1.0 Hz36.251.1635.271.07
3.0 Hz15.070.9517.341.25
0.5 Hz76.891.2639.451.87
cAF1.0 Hz61.321.1061.881.18
3.0 Hz36.991.2737.321.10

2.2 Drug model

Vernakalant reduces the conductance of several atrial ionic currents. We modeled its effect based on Hill’s equation:

(1)Θ=11+(IC50D)nH

with Θ being the degree of channel blockage ranging from 0 to 1,IC50 being the half maximal inhibitory concentration, D being the free drug concentration, and nH being the Hill coefficient. The IC50/nH values for the different currents were extracted from literature for model 1 (M1): 21.0 μM / 0.92 for IKr [2], 13.0 μM / 0.92 for IKur [2], 30.0 μM / 0.82 for Ito [2], and 84.0 μM / 1.0 for ICaL [3]. As a hypothesis, a second model M2 was defined with only ICaL being affected (42.0 μM / 1.0) besides the sodium channel block considered in both M1 and M2.

Due to the frequency dependence of INa block, it can not be represented by a single IC50/nH value pair. Instead, we chose to determine the degree of INa block (gNa reduction) by matching experimentally found reduction of the upstroke velocity dVm/dtmax for each frequency and vernakalant concentration individually. Towards this end, dVm/dtmax at zero drug concentration was taken as a reference value and the INa block in the drug model was tuned to match the experimentally found relative reduction in dVm/dtmax [3]. This optimization was performed in the tissue strand environment described above. Using the degrees of block at 10μM and 30 μM, frequency-specific IC50 /nH value pairs were estimated.

Figure 1 Frequency- and substrate-dependent degree of INa block based on the values for M1 in Table 1. The vertical lines indicate the concentration range investigated in the study by Wettwer et al. [3].
Figure 1

Frequency- and substrate-dependent degree of INa block based on the values for M1 in Table 1. The vertical lines indicate the concentration range investigated in the study by Wettwer et al. [3].

3 Results

The bisection-based tuning of g Na reduction aiming at a replication of experimentally observed dVm/dtmax reduction converged for all substrates, frequencies, and concentrations. The resulting degree of gNa block is shown in Table 2. The degree of INa block increased with increasing frequency as can be seen from the frequency-specific IC50 and nH values in Table 1. This effect is reflected in lower IC50 values as well as in reduced Hill coefficients. Figure 1 reveals that this resulted in a consistently higher degree of block for higher frequencies within a concentration range of 1 – 35μM. The frequency dependence was less pronounced in thecAF substrate than inControl.

The in-silico drug models were used to simulate a train of APs in the tissue strand environment (see Figure 2). In the Control substrate, 2:1 block occured at 3 Hz stimulation frequency using the drug model M1. For all other combinations, APs could be induced continuously, although alternans was observed in some of the models. Besides the upstroke velocity, 6 further AP markers were evaluated for the 6th AP: effective refractory phase (ERP), AP duration at 90% and 20% repolarization (APD90, APD20), AP amplitude (APA), resting membrane potential (RMP), and PLT20 defined as the mean potential in the time window between 20% and 30% repolarization. Table 2 shows the results in comparison to the experimentally observed values in [3]. Model M1 reproduced the ERP prolongation seen in [3].

Table 2

Resulting gNa reduction based on dVm/dtmax tuning and AP markers obtained using the two in-silico models M1 and M2 in comparison to experimentally observed data [3].

gNadVm/dtmaxERPAPD90APD20PLT20APARMP
Control0.5 Hz10μMM1-3.1%-8.3%+4.1%+3.8%+31.0%-0.0%-1.4%-0.2%
M2-3.1%-6.4%-0.6%-0.7%-86.1%+8.4%-1.4%+0.1%
[3]-6.4%-6.5%+129.3%+28.3%-4.5%-1.6%
30μMM1-37.8%-37.8%+16.0%+11.2%+50.0%-6.9%-0.7%-0.3%
M2-38.3%-38.0%-8.2%-10.1%-79.5%+49.0%-10.4%+0.3%
[3]-38.0%-18.7%+475.6%+53.3%-21.0%-6.3%
1.0 Hz10μMM1-18.2%-15.6%+6.4%+5.4%+692.0%+29.5%-4.7%-0.3%
M2-20.7%-19.5%-0.3%-1.5%+295.2%+43.1%-5.1%+0.3%
[3]-17.9%+7.2%+1.2%+135.8%+36.1%-5.4%+0.7%
30μMM1-44.5%-43.9%+18.8%+12.7%+787.1%+17.0%-3.0%-0.5%
M2-45.7%-46.0%-12.4%-15.8%+87.9%+83.6%-12.9%+0.7%
[3]-45.6%+11.0%-4.1%+430.2%+63.3%-18.6%-2.9%
3.0 Hz10μMM1-40.4%-19.1%+844.1%+3.0%-0.4%+3.7%
M2-33.5%-22.5%-5.3%-6.9%+49.6%+14.3%-4.1%+1.7%
[3]-22.1%+10.7%+11.2%+90.1%+4.6%-8.2%-3.2%
30μMM1-65.7%-60.8%+19.4%+710.7%-90.1%+24.0%+3.6%
M2-66.5%-63.1%-8.9%-19.4%+265.5%+46.8%-13.6%+5.5%
[3]-62.7%+31.3%+15.0%+100.8%+52.5%-36.1%-10.4%
cAF0.5 Hz10μMM1-7.1%-7.2%+11.6%+11.9%+52.3%+3.2%-1.7%-0.1%
M2-7.2%-7.3%-8.7%-9.3%-29.3%+6.3%-1.7%+0.0%
[3]-7.3%+7.3%+42.9%+16.1%-4.3%-2.7%
30μMM1-23.4%-23.2%+18.0%+16.6%+75.7%+17.5%-5.9%-0.1%
M2-37.5%-24.2%-17.4%-20.8%-45.6%+20.5%-6.5%+0.0%
[3]-24.3%+16.4%+109.9%-6.9%-10.4%-5.3%
1.0 Hz10μMM1-11.9%-13.2%+12.4%+12.7%+47.5%+7.2%-2.9%-0.1%
M2-10.3%-10.9%-9.5%-10.5%-27.7%+10.0%-2.5%+0.1%
[3]-10.1%+8.5%+5.9%+36.6%+38.0%-3.5%-2.6%
30μMM1-31.2%-31.0%+18.9%+17.3%+67.1%+25.7%-8.2%-0.1%
M2-29.8%-30.9%-19.5%-23.1%-46.6%+26.7%-7.9%+0.1%
[3]-30.3%+30.3%+15.9%+76.4%+52.0%-9.9%-3.9%
3.0 Hz10μMM1-16.0%-15.3%+11.6%+10.5%+56.5%+13.2%-4.2%-0.3%
M2-19.1%-18.5%-5.4%-7.4%-7.1%+16.8%-4.6%+0.4%
[3]-16.2%+16.3%+11.2%+36.7%+800.0%-16.6%-3.9%
M1-43.4%-44.2%+15.6%+10.6%+107.8%+41.0%-12.1%+0.4%
M2-44.0%-45.3%-15.0%-21.4%-11.9%+42.8%-11.8%+1.2%
[3]-43.9%+23.7%+14.1%+40.1%+1070.0%-16.6%-14.3%

However, we did not observe the drug-induced increase of the divergence between ERP and APD90 (ERP prolongation accompanied by APD90 shortening) reported particularly for theControl substrate. Model M2 on the other hand covered the APD90 reduction as well as the increase of PLT 20whilst not replicating the ERP prolongation. The remaining AP markers were replicated sufficiently by both drug models.

4 Discussion

We showed how vernakalant prolongs the atrial refractory period by blocking the potassium currents IKr, IKur, and Ito, as well as the L-type calcium current ICaL in a dose-dependent manner. Furthermore, INa is blocked frequency- and dose-dependently. This model based on literature data from the single channel level (M1) explains what can most probably be considered the major antiar-rhythmic mode of action: ERP prolongation. Our results are in line with the in-vivo human data from Dorian et al. [4] describing a dose dependency but no pronounced frequency dependency of atrial ERP prolongation at frequencies between 1.6 and 3.3 Hz. Atrial ERP was prolonged by between 12 and 14% in [4] for the higher investigated intravenous dose of 4.6 mg/kg.

Our second drug model M2 was comprised of only ICaL and INa block with values for ICaL not being based on subcellular experimental data but chosen to match experimentally observed AP morphology. This model provides a possible explanation of how APD90 and PLT20 are affected by vernakalant based on the delicate balance of inward and outward currents during the AP plateau and repolarization phase. PLT20 has to be considered with caution, though, as APD20 values differ significantly for some of the investigated combinations. Our findings are unlikely to be significantly affected by the choice of the atrial cell model as results using the model by Maleckar et al. [9] were very similar (data not shown).

Figure 2 Vernakalant-induced change of the AP and its frequency dependence for the 2 drug models M1 and M2 in the Control and cAF substrates. AP curves are shown for the 5th beat in the tissue strand. For 3 Hz in the Control substrate, the 6th beat is shown as well because of 2:1 block using drug model M1.
Figure 2

Vernakalant-induced change of the AP and its frequency dependence for the 2 drug models M1 and M2 in the Control and cAF substrates. AP curves are shown for the 5th beat in the tissue strand. For 3 Hz in the Control substrate, the 6th beat is shown as well because of 2:1 block using drug model M1.

While each of the models provides hypotheses for part of the experimentally observed characteristics, none of the setups is capable of reproducing and explaining the entirety of the observed effects. This fact reveals a missing piece of the puzzle in our understanding of vernakalant and throws up new questions. Future work might consider more complex drug models describing frequency-dependent block directly rather than using several Hill formulations. Another aspect, which might need to be covered in order to explain the experimentally observed increase in the difference between ERP and APD90 more comprehensively, is state-dependency.

In conclusion, our results foster the understanding of vernakalant’s cellular mode of action and point out relevant gaps in our current knowledge. This study will thus hopefully fuel and direct future in-silico and experimental research on this aspiring antiarrhythmic agent.


Axel Loewe: Institute of Biomedical Engineering, Karlsruhe Institute of Technology (KIT), Kaiserstr. 12, 76128 Karlsruhe

Author’s Statement

  1. Conflict of interest: Authors state no conflict of interest. Material and Methods: Informed consent: Informed consent has been obtained from all individuals included in this study. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ institutional review board or equivalent committee.

References

[1] Camm, AJ et al.: 2012 focused update of the ESC guidelines for the management of atrial fibrillation. Europace 2012;14:1385– 413.10.1016/j.rec.2012.11.003Suche in Google Scholar

[2] Fedida, D et al.: The mechanism of atrial antiarrhythmic action of RSD1235. J Cardiovasc Elphysiol 2005;16:1227–38.10.1111/j.1540-8167.2005.50028.xSuche in Google Scholar PubMed

[3] Wettwer, E et al.: The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation. Cardiovasc Res 2013;98:145–54.10.1093/cvr/cvt006Suche in Google Scholar PubMed

[4] Dorian, P et al.: The effect of vernakalant (RSD1235), an investigational antiarrhythmic agent, on atrial electrophysiology in humans. J Cardiovasc Pharmacol 2007;50:35–40.10.1097/FJC.0b013e3180547553Suche in Google Scholar PubMed

[5] Courtemanche, M et al.: Ionic mechanisms underlying human atrial action potential properties: Insights from a mathematical model. Am J Physiol 1998;275:H301–21.10.1152/ajpheart.1998.275.1.H301Suche in Google Scholar PubMed

[6] Loewe, A et al.: Influence of chronic atrial fibrillation induced remodeling in a computational electrophysiological model. In Biomed Eng, vol. 59. Walter de Gruyter, Berlin, Boston, 2014; S929–32.Suche in Google Scholar

[7] Seemann, G et al.: Framework for modular, flexible and eflcient solving the cardiac bidomain equation using PETSc. Math Ind 2010;15:363–9.10.1007/978-3-642-12110-4_55Suche in Google Scholar

[8] Loewe, A et al.: In-silico assessment of the dynamic effects of amiodarone and dronedarone on human atrial pathoelectrophysiology. Europace 2014;16:iv30–8.10.1093/europace/euu230Suche in Google Scholar PubMed

[9] Maleckar, MM et al.: K+ current changes account for the rate dependence of the action potential in the atrial myocyte. Am J Physiol Heart Circ Physiol 2009;297:H1398–410.10.1152/ajpheart.00411.2009Suche in Google Scholar PubMed PubMed Central

Published Online: 2015-9-12
Published in Print: 2015-9-1

© 2015 by Walter de Gruyter GmbH, Berlin/Boston

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Artikel in diesem Heft

  1. Research Article
  2. Development and characterization of superparamagnetic coatings
  3. Research Article
  4. The development of an experimental setup to measure acousto-electric interaction signal
  5. Research Article
  6. Stability analysis of ferrofluids
  7. Research Article
  8. Investigation of endothelial growth using a sensors-integrated microfluidic system to simulate physiological barriers
  9. Research Article
  10. Energy harvesting for active implants: powering a ruminal pH-monitoring system
  11. Research Article
  12. New type of fluxgate magnetometer for the heart’s magnetic fields detection
  13. Research Article
  14. Field mapping of ballistic pressure pulse sources
  15. Research Article
  16. Development of a new homecare sleep monitor using body sounds and motion tracking
  17. Research Article
  18. Noise properties of textile, capacitive EEG electrodes
  19. Research Article
  20. Detecting phase singularities and rotor center trajectories based on the Hilbert transform of intraatrial electrograms in an atrial voxel model
  21. Research Article
  22. Spike sorting: the overlapping spikes challenge
  23. Research Article
  24. Separating the effect of respiration from the heart rate variability for cases of constant harmonic breathing
  25. Research Article
  26. Locating regions of arrhythmogenic substrate by analyzing the duration of triggered atrial activities
  27. Research Article
  28. Combining different ECG derived respiration tracking methods to create an optimal reconstruction of the breathing pattern
  29. Research Article
  30. Atrial and ventricular signal averaging electrocardiography in pacemaker and cardiac resynchronization therapy
  31. Research Article
  32. Estimation of a respiratory signal from a single-lead ECG using the 4th order central moments
  33. Research Article
  34. Compressed sensing of multi-lead ECG signals by compressive multiplexing
  35. Research Article
  36. Heart rate monitoring in ultra-high-field MRI using frequency information obtained from video signals of the human skin compared to electrocardiography and pulse oximetry
  37. Research Article
  38. Synchronization in wireless biomedical-sensor networks with Bluetooth Low Energy
  39. Research Article
  40. Automated classification of stages of anaesthesia by populations of evolutionary optimized fuzzy rules
  41. Research Article
  42. Effects of sampling rate on automated fatigue recognition in surface EMG signals
  43. Research Article
  44. Closed-loop transcranial alternating current stimulation of slow oscillations
  45. Research Article
  46. Cardiac index in atrio- and interventricular delay optimized cardiac resynchronization therapy and cardiac contractility modulation
  47. Research Article
  48. The role of expert evaluation for microsleep detection
  49. Research Article
  50. The impact of baseline wander removal techniques on the ST segment in simulated ischemic 12-lead ECGs
  51. Research Article
  52. Metal artifact reduction by projection replacements and non-local prior image integration
  53. Research Article
  54. A novel coaxial nozzle for in-process adjustment of electrospun scaffolds’ fiber diameter
  55. Research Article
  56. Processing of membranes for oxygenation using the Bellhouse-effect
  57. Research Article
  58. Inkjet printing of viable human dental follicle stem cells
  59. Research Article
  60. The use of an icebindingprotein out of the snowflea Hypogastrura harveyi as a cryoprotectant in the cryopreservation of mesenchymal stem cells
  61. Research Article
  62. New NIR spectroscopy based method to determine ischemia in vivo in liver – a first study on rats
  63. Research Article
  64. QRS and QT ventricular conduction times and permanent pacemaker therapy after transcatheter aortic valve implantation
  65. Research Article
  66. Adopting oculopressure tonometry as a transient in vivo rabbit glaucoma model
  67. Research Article
  68. Next-generation vision testing: the quick CSF
  69. Research Article
  70. Improving tactile sensation in laparoscopic surgery by overcoming size restrictions
  71. Research Article
  72. Design and control of a 3-DOF hydraulic driven surgical instrument
  73. Research Article
  74. Evaluation of endourological tools to improve the diagnosis and therapy of ureteral tumors – from model development to clinical application
  75. Research Article
  76. Frequency based assessment of surgical activities
  77. Research Article
  78. “Hands free for intervention”, a new approach for transoral endoscopic surgery
  79. Research Article
  80. Pseudo-haptic feedback in medical teleoperation
  81. Research Article
  82. Feasibility of interactive gesture control of a robotic microscope
  83. Research Article
  84. Towards structuring contextual information for workflow-driven surgical assistance functionalities
  85. Research Article
  86. Towards a framework for standardized semantic workflow modeling and management in the surgical domain
  87. Research Article
  88. Closed-loop approach for situation awareness of medical devices and operating room infrastructure
  89. Research Article
  90. Kinect based physiotherapy system for home use
  91. Research Article
  92. Evaluating the microsoft kinect skeleton joint tracking as a tool for home-based physiotherapy
  93. Research Article
  94. Integrating multimodal information for intraoperative assistance in neurosurgery
  95. Research Article
  96. Respiratory motion tracking using Microsoft’s Kinect v2 camera
  97. Research Article
  98. Using smart glasses for ultrasound diagnostics
  99. Research Article
  100. Measurement of needle susceptibility artifacts in magnetic resonance images
  101. Research Article
  102. Dimensionality reduction of medical image descriptors for multimodal image registration
  103. Research Article
  104. Experimental evaluation of different weighting schemes in magnetic particle imaging reconstruction
  105. Research Article
  106. Evaluation of CT capability for the detection of thin bone structures
  107. Research Article
  108. Towards contactless optical coherence elastography with acoustic tissue excitation
  109. Research Article
  110. Development and implementation of algorithms for automatic and robust measurement of the 2D:4D digit ratio using image data
  111. Research Article
  112. Automated high-throughput analysis of B cell spreading on immobilized antibodies with whole slide imaging
  113. Research Article
  114. Tissue segmentation from head MRI: a ground truth validation for feature-enhanced tracking
  115. Research Article
  116. Video tracking of swimming rodents on a reflective water surface
  117. Research Article
  118. MR imaging of model drug distribution in simulated vitreous
  119. Research Article
  120. Studying the extracellular contribution to the double wave vector diffusion-weighted signal
  121. Research Article
  122. Artifacts in field free line magnetic particle imaging in the presence of inhomogeneous and nonlinear magnetic fields
  123. Research Article
  124. Introducing a frequency-tunable magnetic particle spectrometer
  125. Research Article
  126. Imaging of aortic valve dynamics in 4D OCT
  127. Research Article
  128. Intravascular optical coherence tomography (OCT) as an additional tool for the assessment of stent structures
  129. Research Article
  130. Simple concept for a wide-field lensless digital holographic microscope using a laser diode
  131. Research Article
  132. Intraoperative identification of somato-sensory brain areas using optical imaging and standard RGB camera equipment – a feasibility study
  133. Research Article
  134. Respiratory surface motion measurement by Microsoft Kinect
  135. Research Article
  136. Improving image quality in EIT imaging by measurement of thorax excursion
  137. Research Article
  138. A clustering based dual model framework for EIT imaging: first experimental results
  139. Research Article
  140. Three-dimensional anisotropic regularization for limited angle tomography
  141. Research Article
  142. GPU-based real-time generation of large ultrasound volumes from freehand 3D sweeps
  143. Research Article
  144. Experimental computer tomograph
  145. Research Article
  146. US-tracked steered FUS in a respiratory ex vivo ovine liver phantom
  147. Research Article
  148. Contribution of brownian rotation and particle assembly polarisation to the particle response in magnetic particle spectrometry
  149. Research Article
  150. Preliminary investigations of magnetic modulated nanoparticles for microwave breast cancer detection
  151. Research Article
  152. Construction of a device for magnetic separation of superparamagnetic iron oxide nanoparticles
  153. Research Article
  154. An IHE-conform telecooperation platform supporting the treatment of dementia patients
  155. Research Article
  156. Automated respiratory therapy system based on the ARDSNet protocol with systemic perfusion control
  157. Research Article
  158. Identification of surgical instruments using UHF-RFID technology
  159. Research Article
  160. A generic concept for the development of model-guided clinical decision support systems
  161. Research Article
  162. Evaluation of local alterations in femoral bone mineral density measured via quantitative CT
  163. Research Article
  164. Creating 3D gelatin phantoms for experimental evaluation in biomedicine
  165. Research Article
  166. Influence of short-term fixation with mixed formalin or ethanol solution on the mechanical properties of human cortical bone
  167. Research Article
  168. Analysis of the release kinetics of surface-bound proteins via laser-induced fluorescence
  169. Research Article
  170. Tomographic particle image velocimetry of a water-jet for low volume harvesting of fat tissue for regenerative medicine
  171. Research Article
  172. Wireless medical sensors – context, robustness and safety
  173. Research Article
  174. Sequences for real-time magnetic particle imaging
  175. Research Article
  176. Speckle-based off-axis holographic detection for non-contact photoacoustic tomography
  177. Research Article
  178. A machine learning approach for planning valve-sparing aortic root reconstruction
  179. Research Article
  180. An in-ear pulse wave velocity measurement system using heart sounds as time reference
  181. Research Article
  182. Measuring different oxygenation levels in a blood perfusion model simulating the human head using NIRS
  183. Research Article
  184. Multisegmental fusion of the lumbar spine a curse or a blessing?
  185. Research Article
  186. Numerical analysis of the biomechanical complications accompanying the total hip replacement with NANOS-Prosthetic: bone remodelling and prosthesis migration
  187. Research Article
  188. A muscle model for hybrid muscle activation
  189. Research Article
  190. Mathematical, numerical and in-vitro investigation of cooling performance of an intra-carotid catheter for selective brain hypothermia
  191. Research Article
  192. An ideally parameterized unscented Kalman filter for the inverse problem of electrocardiography
  193. Research Article
  194. Interactive visualization of cardiac anatomy and atrial excitation for medical diagnosis and research
  195. Research Article
  196. Virtualizing clinical cases of atrial flutter in a fast marching simulation including conduction velocity and ablation scars
  197. Research Article
  198. Mesh structure-independent modeling of patient-specific atrial fiber orientation
  199. Research Article
  200. Accelerating mono-domain cardiac electrophysiology simulations using OpenCL
  201. Research Article
  202. Understanding the cellular mode of action of vernakalant using a computational model: answers and new questions
  203. Research Article
  204. A java based simulator with user interface to simulate ventilated patients
  205. Research Article
  206. Evaluation of an algorithm to choose between competing models of respiratory mechanics
  207. Research Article
  208. Numerical simulation of low-pulsation gerotor pumps for use in the pharmaceutical industry and in biomedicine
  209. Research Article
  210. Numerical and experimental flow analysis in centifluidic systems for rapid allergy screening tests
  211. Research Article
  212. Biomechanical parameter determination of scaffold-free cartilage constructs (SFCCs) with the hyperelastic material models Yeoh, Ogden and Demiray
  213. Research Article
  214. FPGA controlled artificial vascular system
  215. Research Article
  216. Simulation based investigation of source-detector configurations for non-invasive fetal pulse oximetry
  217. Research Article
  218. Test setup for characterizing the efficacy of embolic protection devices
  219. Research Article
  220. Impact of electrode geometry on force generation during functional electrical stimulation
  221. Research Article
  222. 3D-based visual physical activity assessment of children
  223. Research Article
  224. Realtime assessment of foot orientation by Accelerometers and Gyroscopes
  225. Research Article
  226. Image based reconstruction for cystoscopy
  227. Research Article
  228. Image guided surgery innovation with graduate students - a new lecture format
  229. Research Article
  230. Multichannel FES parameterization for controlling foot motion in paretic gait
  231. Research Article
  232. Smartphone supported upper limb prosthesis
  233. Research Article
  234. Use of quantitative tremor evaluation to enhance target selection during deep brain stimulation surgery for essential tremor
  235. Research Article
  236. Evaluation of adhesion promoters for Parylene C on gold metallization
  237. Research Article
  238. The influence of metallic ions from CoCr28Mo6 on the osteogenic differentiation and cytokine release of human osteoblasts
  239. Research Article
  240. Increasing the visibility of thin NITINOL vascular implants
  241. Research Article
  242. Possible reasons for early artificial bone failure in biomechanical tests of ankle arthrodesis systems
  243. Research Article
  244. Development of a bending test procedure for the characterization of flexible ECoG electrode arrays
  245. Research Article
  246. Tubular manipulators: a new concept for intracochlear positioning of an auditory prosthesis
  247. Research Article
  248. Investigation of the dynamic diameter deformation of vascular stents during fatigue testing with radial loading
  249. Research Article
  250. Electrospun vascular grafts with anti-kinking properties
  251. Research Article
  252. Integration of temperature sensors in polyimide-based thin-film electrode arrays
  253. Research Article
  254. Use cases and usability challenges for head-mounted displays in healthcare
  255. Research Article
  256. Device- and service profiles for integrated or systems based on open standards
  257. Research Article
  258. Risk management for medical devices in research projects
  259. Research Article
  260. Simulation of varying femoral attachment sites of medial patellofemoral ligament using a musculoskeletal multi-body model
  261. Research Article
  262. Does enhancing consciousness for strategic planning processes support the effectiveness of problem-based learning concepts in biomedical education?
  263. Research Article
  264. SPIO processing in macrophages for MPI: The breast cancer MPI-SNLB-concept
  265. Research Article
  266. Numerical simulations of airflow in the human pharynx of OSAHS patients
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cdbme-2015-0101/html
Button zum nach oben scrollen